Hyperbaric oxygen therapy activates hypoxia-inducible factor 1 (HIF-1), which contributes to improved wound healing in diabetic mice

Wound Repair and Regeneration

Volumn 23, Issue 1, 2015, Pages 98-103

  Sunkari, Vivekananda Gupta ^a,e   Lind, Folke ^b   Botusan, Ileana Ruxandra ^a   Kashif, Abad ^c   Liu, Zhao Jun ^c   Ylä Herttuala, Seppo ^d   Brismar, Kerstin ^a   Velazquez, Omaida ^c   Catrina, Sergiu Bogdan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADENOVIRIDAE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; EXPERIMENTAL SURGICAL WOUND; FIBROBLAST; GENE; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYMIDINE INCORPORATION ASSAY; WESTERN BLOTTING; WOUND HEALING; ANGIOGENESIS; ANIMAL; ANOXIA; C57BL MOUSE; DIABETIC FOOT; EXPERIMENTAL DIABETES MELLITUS; HYPERBARIC OXYGEN THERAPY; METABOLISM; PATHOLOGY;

ANIMALS; ANOXIA; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC FOOT; HYPERBARIC OXYGENATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; WOUND HEALING;

EID: 84928585226     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12253     Document Type: Article

References (40)

1. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J,. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724.
2. Apelqvist J, Larsson J, Agardh CD,. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993; 233: 485-491.
3. Gershater MA, Londahl M, Nyberg P, Larsson J, Thorne J, Eneroth M, et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia 2009; 52: 398-407.
4. Londahl M, Fagher K, Katzman P,. What is the role of hyperbaric oxygen in the management of diabetic foot disease? Curr Diab Rep 2011; 11: 285-293.
5. Tibbles PM, Edelsberg JS,. Hyperbaric-oxygen therapy. N Engl J Med 1996; 334: 1642-1648.
6. Brismar K, Lind F, Kratz G,. Dose-dependent hyperbaric oxygen stimulation of human fibroblast proliferation. Wound Repair Regen 1997; 5: 147-150.
7. Hunt TK, Pai MP,. The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1972; 135: 561-567.
8. Zhao LL, Davidson JD, Wee SC, Roth SI, Mustoe TA,. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg 1994; 129: 1043-1049.
9. Sheikh AY, Gibson JJ, Rollins MD, Hopf HW, Hussain Z, Hunt TK,. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch Surg 2000; 135: 1293-1297.
10. Kang TS, Gorti GK, Quan SY, Ho M, Koch RJ,. Effect of hyperbaric oxygen on the growth factor profile of fibroblasts. Arch Facial Plast Surg 2004; 6: 31-35.
11. Hopf HW, Holm J,. Hyperoxia and infection. Best Pract Res Clin Anaesthesiol 2008; 22: 553-569.
12. Knighton DR, Silver IA, Hunt TK,. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 1981; 90: 262-270.
13. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007; 117: 1249-1259.
14. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858-864.
15. Gallagher KA, Goldstein LJ, Thom SR, Velazquez OC,. Hyperbaric oxygen and bone marrow-derived endothelial progenitor cells in diabetic wound healing. Vascular 2006; 14: 328-337.
16. Kaelin WG Jr,. The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma. Clin Cancer Res 2007; 13 (2 Pt 2): 680s-684.
17. Semenza GL,. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 2009; 24: 97-106.
18. Ahluwalia A, Tarnawski AS,. Critical role of hypoxia sensor-HIF-1alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. Curr Med Chem 2012; 19: 90-97.
19. Elson DA, Ryan HE, Snow JW, Johnson R, Arbeit JM,. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res 2000; 60: 6189-6195.
20. Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L,. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes 2004; 53: 3226-3232.
21. Grabmaier K, AdW MC, Verhaegh GW, Schalken JA, Oosterwijk E,. Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma. Oncogene 2004; 23: 5624-5631.
22. Botusan IR, Sunkari VG, Savu O, Catrina AI, Grunler J, Lindberg S, et al. Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci U S A 2008; 105: 19426-19431.
23. Catrina SB, Botusan IR, Rantanen A, Catrina AI, Pyakurel P, Savu O, et al. Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I. Clin Cancer Res 2006; 12: 4506-4514.
24. Thom SR,. Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol 2009; 106: 988-995.
25. Chandel NS,. Mitochondrial regulation of oxygen sensing. Adv Exp Med Biol 2010; 661: 339-354.
26. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, Neckers LM,. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J Biol Chem 2002; 277: 29936-29944.
27. Cabigas BP, Su J, Hutchins W, Shi Y, Schaefer RB, Recinos RF, et al. Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res 2006; 72: 143-151.
28. Liu YV, Baek JH, Zhang H, Diez R, Cole RN, Semenza GL,. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol Cell 2007; 25: 207-217.
29. Carroll VA, Ashcroft M,. Regulation of angiogenic factors by HDM2 in renal cell carcinoma. Cancer Res 2008; 68: 545-552.
30. Flugel D, Gorlach A, Michiels C, Kietzmann T,. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol Cell Biol 2007; 27: 3253-3265.
31. Tang TT, Lasky LA,. The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 alpha by a von Hippel-Lindau protein-independent mechanism. J Biol Chem 2003; 278: 30125-30135.
32. Bai X, Sun B, Pan S, Jiang H, Wang F, Krissansen GW, et al. Down-regulation of hypoxia-inducible factor-1alpha by hyperbaric oxygen attenuates the severity of acute pancreatitis in rats. Pancreas 2009; 38: 515-522.
33. Calvert JW, Cahill J, Yamaguchi-Okada M, Zhang JH,. Oxygen treatment after experimental hypoxia-ischemia in neonatal rats alters the expression of HIF-1alpha and its downstream target genes. J Appl Physiol 2006; 101: 853-865.
34. Sakata N, Chan NK, Ostrowski RP, Chrisler J, Hayes P, Kim S, et al. Hyperbaric oxygen therapy improves early posttransplant islet function. Pediatr Diabetes 2010; 11: 471-478.
35. Zhang Q, Chang Q, Cox RA, Gong X, Gould LJ,. Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model. J Invest Dermatol 2008; 128: 2102-2112.
36. Thom SR, Milovanova TN, Yang M, Bhopale VM, Sorokina EM, Uzun G, et al. Vasculogenic stem cell mobilization and wound recruitment in diabetic patients: increased cell number and intracellular regulatory protein content associated with hyperbaric oxygen therapy. Wound Repair Regen 2011; 19: 149-161.
37. Milovanova TN, Bhopale VM, Sorokina EM, Moore JS, Hunt TK, Hauer-Jensen M, et al. Hyperbaric oxygen stimulates vasculogenic stem cell growth and differentiation in vivo. J Appl Physiol 2009; 106: 711-728.
38. Andrikopoulou E, Zhang X, Sebastian R, Marti G, Liu L, Milner SM, et al. Current insights into the role of HIF-1 in cutaneous wound healing. Curr Mol Med 2011; 11: 218-235.
39. Kim JW, Tchernyshyov I, Semenza GL, Dang CV,. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3: 177-185.
40. Michaels J, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, et al. db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen 2007; 15: 665-670.